Journal of Biology and Today's World

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance

Abstract

Author(s): Ahmad Hosseini, Mehrnoosh Shanaki, Solaleh Emamgholipour, Manouchehr Nakhjavani, Farideh Razi, Taghi Golmohammadi

"Evidence suggests a hormone peptide named adropin, is involved in lipid metabolism, insulin resistance, and obesity. However, its role in pathogenesis of type 2 diabetes mellitus (T2DM) is still unclear in humans. Therefore, we investigated whether adropin levels are altered in T2DM patients, and evaluated its association with diabetes- related parameters. Men with T2DM (n=40) and age-matched healthy men (n=40) were participated in case-control study. Serum adropin levels were determined by ELISA. Adropin levels were found to be significantly (p=0.004) higher in T2DM patients (median=2.5ng/ml; interquartile range=1.28ng/ml) compared to healthy controls (Median=1.9ng/ml; interquartile range =0.6ng/ml). Adropin was inversely correlated with FBG (Spearman's rho= -0.335; p=0.017) in T2DM patients and was also negatively correlated with HOMA-IR (Spearman's rho= -0.391; p=0.024). Adropin  2.25 ng/ml was the best cut-off point to differentiate T2DM patients from healthy controls (sensitivity= 57.5%; specificity= 82.5%; positive predictive value=76.67%; negative predictive value=66%). We showed that T2DM patients have higher adropin levels, and serum level of adropin is inversely associated with insulin resistance; therefore indicating a close association between adropin and T2DM. However, further studies are necessary to establish the role of adropin in diabetes."

Share this article

Reach Us

Lexispublisher
Avenue Roger Vandendriessche 18,
1150 Brussels, Belgium
Toll Free +32 (800) 709-48

Contact Us

E-Mail: [email protected]

© Lexispublisher 2019 | Creative Commons License Open Access Journals by Lexispublisher is licensed under a Creative Commons Attritbution 4.0 International License

Top